Laboratory Corporation of America Holdings (LH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Laboratory Corporation of America Holdings (LH) has a cash flow conversion efficiency ratio of 0.022x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($191.50 Million) by net assets ($8.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LH equity financing ratio to measure how much of total assets are equity-financed.
Laboratory Corporation of America Holdings - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Laboratory Corporation of America Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Laboratory Corporation of America Holdin to evaluate the quality of earnings relative to operating cash generation.
Laboratory Corporation of America Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Laboratory Corporation of America Holdings ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CIMB Group Holdings Bhd
KLSE:1023
|
0.009x |
|
Northern Star Resources Ltd
AU:NST
|
0.068x |
|
Credicorp Ltd
F:D8V
|
-0.019x |
|
VONOVIA SE ADR 1/2/O.N
F:VNAA
|
0.011x |
|
Reddit, Inc.
NYSE:RDDT
|
0.091x |
|
Schindler Holding AG
SW:SCHN
|
0.116x |
|
EAST JP RAILW. ADR 1/6
F:EJR0
|
N/A |
|
Banco Santander (Brasil) S.A.
SA:SANB11
|
-0.157x |
Annual Cash Flow Conversion Efficiency for Laboratory Corporation of America Holdings (1989–2025)
The table below shows the annual cash flow conversion efficiency of Laboratory Corporation of America Holdings from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see Laboratory Corporation of America Holdin (LH) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $8.64 Billion | $1.64 Billion | 0.190x | -3.38% |
| 2024-12-31 | $8.07 Billion | $1.59 Billion | 0.197x | +16.83% |
| 2023-12-31 | $7.89 Billion | $1.33 Billion | 0.168x | -12.98% |
| 2022-12-31 | $10.12 Billion | $1.96 Billion | 0.193x | -35.99% |
| 2021-12-31 | $10.29 Billion | $3.11 Billion | 0.302x | +33.79% |
| 2020-12-31 | $9.46 Billion | $2.14 Billion | 0.226x | +18.18% |
| 2019-12-31 | $7.56 Billion | $1.44 Billion | 0.191x | +2.31% |
| 2018-12-31 | $6.99 Billion | $1.31 Billion | 0.187x | -14.01% |
| 2017-12-31 | $6.72 Billion | $1.46 Billion | 0.217x | +1.97% |
| 2016-12-31 | $5.52 Billion | $1.18 Billion | 0.213x | +11.47% |
| 2015-12-31 | $5.14 Billion | $982.40 Million | 0.191x | -26.62% |
| 2014-12-31 | $2.84 Billion | $739.00 Million | 0.260x | -21.09% |
| 2013-12-31 | $2.48 Billion | $818.70 Million | 0.330x | +7.95% |
| 2012-12-31 | $2.75 Billion | $841.40 Million | 0.306x | -9.84% |
| 2011-12-31 | $2.52 Billion | $855.60 Million | 0.339x | +1.10% |
| 2010-12-31 | $2.63 Billion | $883.60 Million | 0.335x | -12.57% |
| 2009-12-31 | $2.25 Billion | $862.40 Million | 0.384x | -11.12% |
| 2008-12-31 | $1.81 Billion | $780.90 Million | 0.432x | +4.91% |
| 2007-12-31 | $1.73 Billion | $709.70 Million | 0.411x | +28.62% |
| 2006-12-31 | $1.98 Billion | $632.30 Million | 0.320x | +5.03% |
| 2005-12-31 | $1.89 Billion | $574.20 Million | 0.305x | +11.71% |
| 2004-12-31 | $1.97 Billion | $538.10 Million | 0.273x | -8.42% |
| 2003-12-31 | $1.90 Billion | $564.30 Million | 0.298x | +9.92% |
| 2002-12-31 | $1.64 Billion | $444.90 Million | 0.271x | -7.00% |
| 2001-12-31 | $1.09 Billion | $316.00 Million | 0.291x | +3.54% |
| 2000-12-31 | $877.40 Million | $246.70 Million | 0.281x | +14.37% |
| 1999-12-31 | $734.20 Million | $180.50 Million | 0.246x | +33.87% |
| 1998-12-31 | $681.20 Million | $125.10 Million | 0.184x | -19.88% |
| 1997-12-31 | $630.00 Million | $144.40 Million | 0.229x | +131.67% |
| 1996-12-31 | $258.10 Million | $-186.80 Million | -0.724x | -733.82% |
| 1995-12-31 | $411.60 Million | $47.00 Million | 0.114x | +28.95% |
| 1994-12-31 | $166.00 Million | $14.70 Million | 0.089x | -78.20% |
| 1993-12-31 | $140.80 Million | $57.20 Million | 0.406x | -14.36% |
| 1992-12-31 | $212.50 Million | $100.80 Million | 0.474x | +17.10% |
| 1991-12-31 | $330.80 Million | $134.00 Million | 0.405x | -7.49% |
| 1990-12-31 | $256.70 Million | $112.40 Million | 0.438x | +101.25% |
| 1989-12-31 | $330.00 Million | $71.80 Million | 0.218x | -- |
About Laboratory Corporation of America Holdings
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcoh… Read more